Sage Therapeutics Inc. (SAGE) - P/E multiplikatori

Sage Therapeutics Inc (SAGE) brendining ramzi va logotipi

GURU.Markets dagi narxlar grafigi Sage Therapeutics, Inc. (SAGE) kompaniyasining -1.80 miqdoridagi P/E koeffitsiyenti bilan qat'iy xarajatlarni optimallashtirish sharoitida o'z mahsulotlar portfelini kengaytirishga qiynalayotganini ko'rsatmoqda. Kompaniya markaziy nerv tizimi buzilishlarini davolash sohasida yetakchilik qiladi va tug'ruqdan keyingi depressiya uchun noyob, tez ta'sir qiluvchi vositani taklif etadi. Biznes juda ixtisoslashgan ishlanmalarni monetizatsiya qiladi va mustahkam patent portfeli orqali o'z bozor nishasini himoya qiladi.

SAGE Sage Therapeutics, Inc P/E multiplikatori (04.07.2022 - 16.08.2025)

Sage Therapeutics, Inc (SAGE) kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Sage Therapeutics - SAGE
Sage Therapeutics Inc. yetakchi tovari

Sage Therapeutics, Inc. (SAGE) operatsion xarajatlarni optimallashtirish uchun sog'liqni saqlash giganti bilan strategik ittifoq orqali dori vositalarini tijoratlashtirish modelini ishlab chiqmoqda. P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini aks ettirib, investitsiyalarning qoplanish muddatini belgilaydi. Ushbu ko'rsatkich aktivning haqiqiy daromadlariga nisbatan fundamental past baholanganligini aniqlash imkonini beradi. Emitentning P/E grafigini tahlil qilish narx anomaliyalarini filtrlashga yordam beradi. Balans hisobotining puxta auditi kapitalning muzlatilishi xavfining oldini oladi.

Muhim raqobatchilar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea|Narx-foyda multiplikatori CRGT (Cortigent)|Narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Narx-foyda koeffitsiyenti|ELYM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Narxning foydaga nisbati|Marinus - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori